Biomarkers in Kidney Transplantation

Biomarkers in Kidney Transplantation: Clinical Aspects and Laboratory Determination provides a focused study on traditional and emerging biomarkers to predict early rejection of kidney transplants supporting appropriate therapeutic interventions. Coverage includes predictive and diagnostic biomarkers for different types of rejections, including biomarkers of acute, chronic/sub chronic rejection or clinical rejection, T-cell mediated rejection, antibody mediated rejection and mixed rejection. Comparisons are provided for broad classification of pharmacokinetic versus pharmacodynamic biomarkers, and differentiation is shown between the susceptibility, diagnostic, predictive, prognostic and monitoring biomarkers.
Coverage of the analytical aspects of biomarker measurement, the process of biomarker discovery and their clinical validation addresses both the clinical features of biomarkers as well as the pitfalls of determining such biomarkers in clinical laboratories. By combining all current markers known for kidney transplant in one collection, this easy-to-use reference is perfect for pathologists, clinical pharmacologists, clinical laboratory scientists and all physicians involved in organ transplantation, including immunologists and transplant surgeons.

Smita Pattanaik received her MBBS from Utkal University, an MD in Pharmacology from PGIMER Chandigarh, DNB in Pharmacology from National Board of Examination New Delhi and DM in Clinical Pharmacology from PGIMER Chandigarh. Her current research focuses on concentrate on clinical pharmacology of immunosuppressant drugs, therapeutic drug monitoring and dose individualization (PK/PD) modeling and pharmacogenomics, clinical research methodology and biostatistics, clinical pharmacology of genitourinary system and bladder cancer chemotherapy.